Effect of spironolactone on physical performance in older people with self-reported physical disability

American Journal of Medicine

Volumn 126, Issue 7, 2013, Pages 590-597

  Burton, Louise A ^a   Sumukadas, Deepa ^a   Witham, Miles D ^a   Struthers, Allan D ^a   McMurdo, Marion E T ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Angiotensin converting enzyme; Renin angiotensin aldosterone system; Spironolactone

Indexed keywords

PLACEBO; SPIRONOLACTONE;

AGED; ARTICLE; BLOOD SAMPLING; COMORBIDITY; DAILY LIFE ACTIVITY; FEMALE; HEART FAILURE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PHYSICAL PERFORMANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZATION; SELF REPORT; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; RENIN-ANGIOTENSIN SYSTEM; SPIRONOLACTONE; WALKING;

EID: 84879144923     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.11.032     Document Type: Article

References (30)

1. T. Rantanen, J.M. Guralnik, and R. Sakari-Rantala Disability, physical activity, and muscle strength in older women: the Women's Health and Aging Study Arch Phys Med Rehabil 80 1999 130 135
2. G. Onder, B.W. Penninx, and R. Balkrishnan Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study Lancet 359 2002 926 930
3. D. Sumukadas, M.D. Witham, A.D. Struthers, and M.E. McMurdo Effect of perindopril on physical function in elderly people with functional impairment: a randomized controlled trial CMAJ 177 2007 867 874
4. M. Cesari, C. Pedone, R.A. Incalzi, and M. Pahor ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study J Am Med Dir Assoc 11 2010 26 32
5. J.G. Burniston, A. Saini, L.B. Tan, and D.F. Goldspink Aldosterone induces myocyte apoptosis in the heart and skeletal muscles of rats in vivo J Mol Cell Cardiol 39 2005 395 399
6. M. Cicoira, L. Zanolla, and L. Franceschini Relation of aldosterone "escape" despite angiotensin-converting enzyme inhibitor administration to impaired exercise capacity in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 89 2002 403 407
7. T. Dyckner, P.O. Wester, and L. Widman Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension Eur J Clin Pharmacol 30 1986 535 540
8. N.K. Aagaard, H. Andersen, and H. Vilstrup Muscle strength, Na, K-pumps, magnesium and potassium in patients with alcoholic liver cirrhosis-relation to spironolactone J Intern Med 252 2002 56 63
9. J. Francis, T. Beltz, A.K. Johnson, and R.B. Felder Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-alpha in normal rats Am J Physiol Regul Integr Comp Physiol 285 2003 R1402 R1409
10. K. Bendtzen, P.R. Hansen, and K. Rieneck Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis Clin Exp Immunol 134 2003 151 158
11. D.L. Clement Effect of spironolactone on systemic blood pressure, limb blood flow and response to sympathetic stimulation in hypertensive patients Eur J Clin Pharmacol 21 1982 263 267
12. C.A. Farquharson, and A.D. Struthers Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy Clin Sci (Lond) 103 2002 425 431
13. K. Jensen-Urstad, F. Bouvier, and J. Hojer Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy Am J Cardiol 81 1998 538 544
14. P.L. Enright, M.A. McBurnie, and V. Bittner The 6-min walk test: a quick measure of functional status in elderly adults Chest 123 2003 387 398
15. S.J. Singh, M.D. Morgan, and S. Scott Development of a shuttle walking test of disability in patients with chronic airways obstruction Thorax 47 1992 1019 1024
16. C.A. Dyer, S.J. Singh, and R.A. Stockley The incremental shuttle walking test in elderly people with chronic airflow limitation Thorax 57 2002 34 38
17. A. Shumway-Cook, S. Brauer, and M. Woollacott Predicting the probability for falls in community-dwelling older adults using the Timed Up & Go Test Phys Ther 80 2000 896 903
18. D. Podsiadlo, and S. Richardson The timed "Up & Go": a test of basic functional mobility for frail elderly persons J Am Geriatr Soc 39 1991 142 148
19. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatr Scand 67 1983 361 370
20. B. Pollard, and M. Johnston Problems with the sickness impact profile: a theoretically based analysis and a proposal for a new method of implementation and scoring Soc Sci Med 52 2001 921 934
21. M.D. Witham, J.M. Gray, and I.S. Argo Effect of a seated exercise program to improve physical function and health status in frail patients > or = 70 years of age with heart failure Am J Cardiol 95 2005 1120 1124
22. S. Perera, S.H. Mody, R.C. Woodman, and S.A. Studenski Meaningful change and responsiveness in common physical performance measures in older adults J Am Geriatr Soc 54 2006 743 749
23. A. Deswal, P. Richardson, B. Bozkurt, and D.L. Mann Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF) J Card Fail 17 2011 634 642
24. A.S. Pickard, M.P. Neary, and D. Cella Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer Health Qual Life Outcomes 5 2007 70
25. N.P. Hurst, P. Jobanputra, and M. Hunter Validity of Euroqol-a generic health status instrument-in patients with rheumatoid arthritis. Economic and Health Outcomes Research Group Br J Rheumatol 33 1994 655 662
26. M. Cicoira, L. Zanolla, and A. Rossi Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure J Am Coll Cardiol 40 2002 304 310
27. S.D. Hutcheon, N.D. Gillespie, and I.K. Crombie Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial Heart 88 2002 373 377
28. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
29. R. Rocha, A.E. Rudolph, and G.E. Frierdich Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 2002 H1802 H1810
30. K. Swaminathan, J. Davies, and J. George Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles Diabetologia 51 2008 762 768